Published in Oncogene on March 13, 2006
Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays. Genome Biol (2009) 2.88
Whole genome scanning as a cytogenetic tool in hematologic malignancies. Blood (2008) 1.78
Application of OMICS technologies in occupational and environmental health research; current status and projections. Occup Environ Med (2009) 1.67
Identifying selected regions from heterozygosity and divergence using a light-coverage genomic dataset from two human populations. PLoS One (2008) 1.54
Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations. Blood (2008) 1.30
Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype. Haematologica (2009) 1.17
CanProVar: a human cancer proteome variation database. Hum Mutat (2010) 1.15
Direct inference of SNP heterozygosity rates and resolution of LOH detection. PLoS Comput Biol (2007) 1.06
Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma. Int J Cancer (2009) 0.94
A brief review of molecular techniques to assess plant diversity. Int J Mol Sci (2010) 0.94
Site-specific labeling of T7 DNA polymerase with a conformationally sensitive fluorophore and its use in detecting single-nucleotide polymorphisms. Anal Biochem (2008) 0.88
Snap-to-it probes: chelate-constrained nucleobase oligomers with enhanced binding specificity. Nucleic Acids Res (2008) 0.87
High-throughput genomic technology in research and clinical management of breast cancer. Evolving landscape of genetic epidemiological studies. Breast Cancer Res (2006) 0.86
The regulatory mechanism of the LY6K gene expression in human breast cancer cells. J Biol Chem (2012) 0.84
Effects of environment, genetics and data analysis pitfalls in an esophageal cancer genome-wide association study. PLoS One (2007) 0.83
DMET™ (Drug Metabolism Enzymes and Transporters): a Pharmacogenomic platform for precision medicine. Oncotarget (2016) 0.80
Integrative approach detected association between genetic variants of microRNA binding sites of TLRs pathway genes and OSCC susceptibility in Chinese Han population. PLoS One (2014) 0.76
Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes. Front Immunol (2017) 0.75
Predictive and prognostic molecular markers for cholangiocarcinoma in Han Chinese population. Int J Clin Exp Med (2015) 0.75
MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects. Onco Targets Ther (2017) 0.75
[Molecular pathology as an necessity: its role in diagnostic and predictive pathology]. Pathologe (2009) 0.75
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (2009) 13.45
Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort. Neurology (2009) 1.83
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology (2009) 1.67
Motoneuron-specific NR3B gene: no association with ALS and evidence for a common null allele. Neurology (2007) 1.48
Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol Cell Biol (1994) 1.34
Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B Neuropsychiatr Genet (2011) 1.26
Molecular characterization of a cluster of at least two glucosyltransferase genes in Streptococcus salivarius ATCC 25975. J Gen Microbiol (1991) 1.25
Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centre. Colorectal Dis (2009) 1.17
A chloroplast transcript lacking the 3' inverted repeat is degraded by 3'-->5' exoribonuclease activity. RNA (1996) 1.07
Determination of the allelic frequency in Smith-Lemli-Opitz syndrome by analysis of massively parallel sequencing data sets. Clin Genet (2014) 1.02
Sequence of the gtfK gene of Streptococcus salivarius ATCC 25975 and evolution of the gtf genes of oral streptococci. J Gen Microbiol (1993) 0.97
Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS. Neurology (2008) 0.94
Toxicological and antiproliferative effects of N6-(delta2-isopentenyl) adenosine, a natural component of mammalian transfer RNA. Cancer Res (1970) 0.87
Misrepresentation of medical students in teaching hospitals. Med Trial Tech Q (1977) 0.82
Isolation of a candidate gene for choroideremia. Proc Natl Acad Sci U S A (1992) 0.81
A dominant mutation in the Chlamydomonas reinhardtii nuclear gene SIM30 suppresses translational defects caused by initiation codon mutations in chloroplast genes. Genetics (1997) 0.80
Comparative study of the toxicologic effects of 7-deazaadenosine (tubercidin) and 7-deazainosine. Cancer Res (1969) 0.79
Toxic and patologic effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone), a new antileukemic agent. Cancer Res (1969) 0.79
Thyroid enlargement in Lake Erie coho salmon. J Natl Cancer Inst (1974) 0.76
Kethoxal bis(thiosemicarbazone). II. Toxic and pathologic effects. Cancer Res (1965) 0.75
The pathology of laser irradiation of the skin and body wall of the mouse. Am J Pathol (1965) 0.75
Primary sarcoma of penis. Urology (1982) 0.75
Pathology of internal viscera following laser irradiation. Am J Med Sci (1969) 0.75
Antitumor and toxicologic effects of p-carboxycarbanilic acid, N-(p-(bis(2-chloroethyl)amino)phenyl) ester (NSC-130998; IC 140). Cancer Chemother Rep (1970) 0.75
Prevention by testosterone of the intestinal toxicity caused by the antitumor agent 3-deazauridine. Cancer Res (1974) 0.75
The prevention of cyclophosphamide-induced bladder swelling in the rat by I.V. administration of sodium-2-mercaptoethane sulfonate. Res Commun Chem Pathol Pharmacol (1980) 0.75